Assemblée Nationale du Québec {PNG}On 4th July, Genopole was honoured to host a delegation of parliamentarians from the Quebec National Assembly and the French Senate as part of the 2016 activities of the Groupe Interparlementaire d’Amitié France-Québec.
This organisation has been very active in fostering exchanges between parliamentarians from France and Quebec for over half a century.

Denis GauvreauThis year’s focus for the group’s work pertains to the ethical and legal implications of the use of CRISPR-Cas9 in various fields of applications. CRISPR-Cas9 is a unique technology that enables geneticists and medical researchers to edit parts of the genome by cutting out, replacing or adding parts to the DNA sequence.
It is currently the simplest, most versatile and precise method of genetic manipulation.

JF. DELEUZEThroughout the day, engaging presentations were made by Jean-François Deleuze, Director of National Genotyping Center (CNG), on personalised medicine, Anne Galy, Director of INTEGRARE, on gene therapy, and Annelise Bennaceur Griscelli, Director of Inserm U935 "Malignant and Therapeutic Stem Cell Models" and "ESTeam Paris Sud" Stem Cell ES, on cell therapy.
This most recent visit by Quebeckers is part of a series of events organised with different Quebec organisations to promote collaborative exchanges between the two communities who are active in genomics-driven R&D and genomics-derived innovation. The delegation was enthusiastic about the presentations and hopes to return very soon to Genopole for more fruitful exchanges.

The delegation of parliamentarians from the Quebec National Assembly and the French Senate
@Genopole